Home
>
National Drug Code (NDC)
>
NAPRELAN
NAPRELAN - 43063-242-30 - (naproxen sodium)
Drug Information of NAPRELAN
| Product NDC: | 43063-242 |
| Proprietary Name: | NAPRELAN |
| Non Proprietary Name: | naproxen sodium |
| Active Ingredient(s): | 750 mg/1 & nbsp; naproxen sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NAPRELAN
| Product NDC: | 43063-242 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020353 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20081219 |
Package Information of NAPRELAN
| Package NDC: | 43063-242-30 |
| Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43063-242-30) |
NDC Information of NAPRELAN
| NDC Code | 43063-242-30 |
| Proprietary Name | NAPRELAN |
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43063-242-30) |
| Product NDC | 43063-242 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | naproxen sodium |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20081219 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | NAPROXEN SODIUM |
| Strength Number | 750 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
